Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Hypoxia Prevention in High-risk Patients Undergoing Painless Bronchoscopy
NCT07395596Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in hypoxia, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Started Feb 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
hypoxia
Beyond the preview
Go deeper on NCT07395596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07395596.